GeoMx™ Digital Spatial Profiler: Q&A with Trieu My Van, PhD., NKI, Netherlands Cancer Institute, Christian Blank Lab

https://www.youtube.com/watch?v=M5xfd143_a0&feature=youtu.be What was the most surprising thing about using the GeoMx DSP platform?I was quite surprised about the high amount of data that's coming out of the platform from only a single FFPE tissue. This allows us to get better...

/ September 9, 2019

A Strategic Attack Against Neurological Diseases

Neurological diseases are often multifactorial, brought on by a genetic and environmental tug-of-war and resulting in multifaceted clinical presentations. Such etiological complexity has hindered treatment progress and has necessitated well-thought-out and systematic strategies of attack to mitigate their global burden....

/ September 3, 2019

Experts Discuss Digital Spatial Profiling in Immuno-Oncology

The selective efficacy of immunotherapies continues to provide impetus for innovative solutions that can facilitate a deeper molecular interrogation of cancer biology. Researchers are increasingly adopting high-throughput technologies that capture morphological details, to elucidate cell-matrix adhesive interactions and their governance...

/ August 26, 2019

Q&A with Dr. Maureen McGargill, PhD: The Immune System’s Fine Line Between Health and Harm

Dr. McGargill earned her PhD at the University of Minnesota in Dr. Kristin Hogquist’s lab. There she studied T cell development, focusing on how autoreactive T cells are deleted during development. As a postdoc at the University of California, San...

miRNA Profiling in Malignant Melanoma: Making “Australia’s National Cancer” Obsolete.

Australia is a sun-worshipping country, the world capital for beautiful beaches, athletic surfers, cute marsupials, and the occasional weird-looking animal. But it is also the capital for something less pleasant: skin cancer. In fact, at least two in three Australians...

/ August 12, 2019